Eric dEsparbes - 15 Mar 2023 Form 4 Insider Report for BIORA THERAPEUTICS, INC. (BIORQ)

Role
Chief Financial Officer
Signature
/s/ Will Pridgen, Attorney-in-Fact for Eric d'Esparbes
Issuer symbol
BIORQ
Transactions as of
15 Mar 2023
Net transactions value
-$28,713
Form type
4
Filing time
17 Mar 2023, 21:16:50 UTC
Previous filing
17 Feb 2023
Next filing
17 May 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BIOR Common Stock Award $0 +62,225 +221% $0.000000 90,365 15 Mar 2023 Direct F1
transaction BIOR Common Stock Award $0 +22,692 +25% $0.000000 113,057 15 Mar 2023 Direct F2
transaction BIOR Common Stock Tax liability $28,713 -11,216 -9.9% $2.56 101,841 15 Mar 2023 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of 62,225 restricted stock units ("RSUs"), 25% of which will vest on May 15, 2024, with the remaining shares vesting in equal semi-annual installments through May 15, 2027, subject to the Reporting Person's continued service to the Issuer.
F2 Consists of 22,692 RSUs, which vested upon grant.
F3 Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the release of vested RSUs.